Darunavir 300mg Tablet

Darunavir 300mg Tablet is a prescription antiretroviral medication used as part of combination therapy for the treatment of Human Immunodeficiency Virus (HIV-1) infection. It belongs to the protease inhibitor class, which works by targeting a critical enzyme required for viral replication. Darunavir is widely recommended in HIV treatment guidelines due to its effectiveness and high genetic barrier to resistance when used with other antiretroviral agents.

This medication is commonly prescribed for both treatment-naïve and treatment-experienced patients, including those with resistance to other protease inhibitors. Darunavir 300mg Tablet helps reduce viral load in the blood and supports immune system recovery by increasing CD4 cell counts. It is usually administered with a pharmacokinetic booster and other antiretroviral medicines under strict medical supervision.

The 300 mg Darunavir tablet is produced in accordance with strict pharmaceutical quality standards to guarantee consistency, safety, and effectiveness. A key component of long-term HIV care, this medication is provided for clinical, hospital, and institutional usage as part of all-encompassing antiretroviral treatment regimens.

Product Features

• Contains 300 mg of Darunavir as the active ingredient
• Protease inhibitor for HIV-1 treatment
• High resistance barrier compared to other HIV drugs
• Used in combination with antiretroviral therapy (ART)
• Manufactured under GMP-compliant pharmaceutical standards

How It Helps

• Inhibits HIV protease enzyme to prevent viral replication
• Reduces HIV viral load in the bloodstream
• Helps improve CD4 cell count and immune function
• Supports long-term HIV infection management
• Enhances treatment outcomes when combined with other ART drugs